avatar

Auto-generated profile, based on publicly available information


Research Focus & Metrics

Representative Publications

View All Publications
27 June 2024 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
DSDaniel Schultz
Daniel Schultz
ACAlejandra Chávez-Riveros
Alejandra Chávez-Riveros
MGMichael G. Goertzen
Michael G. Goertzen
BBBeau R. Brummel
Beau R. Brummel
RPRaphaella A. Paes
Raphaella A. Paes
RIRobert W. Huigens III
Robert W. Huigens III
A chloroformate-mediated ring cleavage of indole alkaloids enabled the rapid synthesis of 47 diverse and complex small molecules, including derivatives from reserpine that demonstrate interesting activities against Plasmodium falciparum parasites .

3 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAlexandra Kolas
Alexandra Kolas
YRYudi Rusman
Yudi Rusman
AMAna C.G. Maia
Ana C.G. Maia
JWJessica Williams
Jessica Williams
FFFernanda G. Fumuso
Fernanda G. Fumuso
CSChristine Salomon
Christine Salomon
Cryptosporidium is a common, waterborne gastrointestinal parasite that causes diarrheal disease worldwide. Currently there are no effective therapeutics to treat cryptosporidiosis in at-risk populations. Since natural products are a known source of anti-parasitic compounds, we screened a library of extracts and pure natural product compounds isolated from bacteria and fungi collected from subterranean environments for activity against Cryptosporidium parvum . Eight structurally related norditerpene lactones isolated from the fungus Oidiodendron truncatum collected from the Soudan Iron mine in Minnesota showed potent activity and were further tested to identify the most active compounds. The availability of a diverse suite of natural structural analogs with varying activities allowed us to determine some structure activity relationships for both anti-parasitic activity as well as cytotoxicity. The two most potent compounds, oidiolactones A and B, had EC 50 s against intracellular Cryptosporidium parvum of 530 and 240 nM respectively without cytotoxicity to confluent HCT-8 host cells. Both compounds also inhibited the related parasite Toxoplasma gondii . Oidiolactone A was active against asexual, but not sexual, stages of C. parvum , and killed 80% of the parasites within 8 hours of treatment. This compound reduced C. parvum infection by 70% in IFNγ−/− mice, with no signs of toxicity. The high potency, low cytotoxicity, and in vivo activity combined with high production, easy isolation from fungi, and synthetic accessibility make oidiolactones A and B attractive scaffolds for the development of new anti- Cryptosporidium therapeutics.

29 May 2024 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JCJennifer E. Collins
Jennifer E. Collins
TJTiantian Jiang
Tiantian Jiang
JLJin Woo Lee
Jin Woo Lee
KWKaren Wendt
Karen Wendt
FNFlore Nardella
Flore Nardella
DCDebopam Chakrabarti
Debopam Chakrabarti

18 February 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
TJTiantian Jiang
Tiantian Jiang
JLJin Woo Lee
Jin Woo Lee
JCJennifer E. Collins
Jennifer E. Collins
SSSamuel Schaefer
Samuel Schaefer
DCDaisy Chen
Daisy Chen
EWElizabeth A. Winzeler
Elizabeth A. Winzeler
Herein we report the finding and structure determination of a natural product based on the methyldeoxaphomin scaffold family from the fungus Trichocladium asperum that shows promising antiplasmodial activity and selectivity against host cells. In vitro evolution and whole genome analysis in Plasmodium falciparum with the most potent member, NPDG-F (EC 50 of 550 nM in Dd2; 290 nM in 3D7), shows that parasite resistance to methyldeoxaphomins is strongly associated with mutations in PfActin1 (PF3D7_1246200), a critically essential ATPase needed for all stages of parasite development. Molecular docking study with available PfActin1 crystal structure shows NPDG-F occupies the same allosteric binding pocket as the known actin inhibitor cytochalasin D. The direct PfActin1 target engagement in the allosteric site was supported by cross-resistance studies, isobologram analysis with other PfActin1 inhibitors, and the structure–activity relationships for the methyldeoxaphomin family. When added to in vitro culture, NPDG-F induced morphological abnormalities in merozoite cellularization during schizogony in both the Plasmodium blood and liver stages. Our data provide chemical validation that PfActin1 is an attractive, pan-lifecycle target and inform strategies for the design of more selective inhibitors.

4 November 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
AKAlexandra Kolas
Alexandra Kolas
YRYudi Rusman
Yudi Rusman
AMAna Carolina R G Maia
Ana Carolina R G Maia
JWJessica Williams
Jessica Williams
Jiashu XieJiashu Xie
Jiashu Xie
CSChristine Salomon
Christine Salomon
Cryptosporidium is a waterborne gastrointestinal parasite that causes diarrheal disease worldwide. Currently, there are no effective therapeutics to treat cryptosporidiosis. Since natural products are a known source of anti-parasitic compounds, we screened a library of extracts and pure compounds isolated from bacteria and fungi collected from subterranean environments for anti-Cryptosporidium activity. Seven norditerpene lactones isolated from the fungus Oidiodendron truncatum collected from the Soudan Iron mine in Minnesota showed potent activity and were further tested to identify the most active compounds. The availability of a diverse suite of natural structural analogs with varying activities allowed us to determine some structure–activity relationships for both anti-parasitic activity and cytotoxicity. The two most potent compounds, oidiolactones A and B, had EC50s against C. parvum of 530 and 240 nM, respectively, without cytotoxicity to host cells. Both compounds also inhibited the related parasite Toxoplasma gondii. Oidiolactone A was active against asexual, but not sexual, stages of C. parvum, and killed parasites within 8 h of treatment. This compound reduced C. parvum infection by 70% in IFNγ−/− mice, with no signs of toxicity. The high potency, low cytotoxicity, and in vivo activity combined with high production and synthetic accessibility make these oidiolactones attractive scaffolds for the development of new anti-Cryptosporidium therapeutics.